Eric Schenkel, MD
Allergy & Immunology · Bethlehem, PANPI 1306958939
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $659,923 of the $844,555 with a category attached, or 78.1%. 42 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 36.3% of the total. Reporting peaked in 2023 at $170,851 and has fallen 56.5% since, to $74,238 in 2025. Among allergy & immunology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,568 payments — averaging $538.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$306K
- Sanofi$204K
- AstraZeneca$138K
- GSK$73K
- Optinose US, Inc.$63K
- Alk-abello, Inc$18K
- plus $42K from 36 others
Across 1 payment — averaging $60.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$61
What the payments were for
- Consulting fees$38,0515%
- Speaking & faculty fees$659,92378%
- Travel & lodging$111,76213%
- Food & beverage$34,6734%
- Education$1470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$525,436
- NUCALA$72,097
- Xhance$61,648
- FASENRA$48,334
- TEZSPIRE$45,795
- AIRSUPRA$31,628
- Odactra$17,212
- CINRYZE$13,275
- RUCONEST$4,110
- NO PRODUCT DISCUSSED$2,359
- ArmonAir Digihaler$1,680
- ProAir Digihaler$1,680
- AirDuo RespiClick$1,680
- BioFire FilmArray$142
- Ragwitek$117
- Grastek$117
- VTAMA$112
How this compares
$844,555 in reported general payments places this provider in the 95th percentile of 175 allergy & immunology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 22 | $120,175 |
| Breo ElliptaFluticasone/Vilanterol | 93 | $66,195 |
| Arnuity ElliptaFluticasone Furoate | 100 | $40,573 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $35,899 |
| Qvar RedihalerBeclomethasone Dipropionate | 59 | $24,763 |
| XhanceFluticasone Propionate | 19 | $19,099 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $17,308 |
| AsmanexMometasone Furoate | 21 | $7,177 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 25 | $5,547 |
| Epinephrine | 25 | $5,294 |
| Asmanex HfaMometasone Furoate | 34 | $4,818 |
| Montelukast Sodium | 330 | $4,774 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 102 | $4,281 |
| Mometasone Furoate | 18 | $3,252 |
| Ipratropium Bromide | 70 | $3,080 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta, Trelegy Ellipta | $73,287 | $142,666236 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $1,839 | $24,76359 claims |
| Optinose US, Inc.Xhance | $62,818 | $19,09919 claims |
| AstraZenecaBreztri Aerosphere | $137,912 | $17,30821 claims |
| MerckAsmanex | $6,256 | $7,17721 claims |
| Hikma Pharmaceuticals USAEpinephrine | $81 | $5,29425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 175 allergy & immunology providers in Pennsylvania.
Other allergy & immunology in Bethlehem
- Yifeng ChenBethlehem$9K
- Drew WeissmanPhiladelphia$12.8M
- Sergei BelenkyPittsburgh$775K
- Timothy CraigHershey$564K
- Sandra GawchikUpland$390K
- Anthony RooklinGlen Mills$319K
- Corinna BowserNarberth$229K
- Shailen ShahCollegeville$183K
- Michael PremattaHavertown$168K
- Donald HarperMechanicsburg$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.